In Utero Hematopoietic Stem Cell Transplantation for Alpha-thalassemia Major (ATM)

Clinical trial NCT02986698 · TERMINATED

Trial details

NCT number: NCT02986698
Sponsor: University of California, San Francisco
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Alpha Thalassemia Major Hemoglobinopathy; With Thalassemia Hemoglobinopathies Fetal Anemia Fetal Hydrops Alpha; Thalassemia Thalassemia Major Thalassemia Alpha A-Thalassemia

Start date: 2017-10-05
Primary completion: 2024-04-30
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.